Deadline for submission: April 10!

We want you! Scientific committee calls for cutting-edge science at Probiota Americas 2015

By Stephen Daniells

- Last updated on GMT

We want you! Scientific committee calls for cutting-edge science at Probiota Americas 2015

Related tags Probiota americas Probiotic

A newly established scientific committee is set to assess cutting edge research for the Probiota Americas 2015 Scientific Frontiers poster session. Don’t miss your chance to present!
microbiota

The NutraIngredients-USA and Probiota Americas team are inviting abstract proposals from academic researchers and industry professionals on the latest state-of-the-art developments​ related to all aspects of prebiotic, probiotic​ and microbiome​ science relevant to health, well-being, consumers and industry ahead of Probiota Americas 2015.

All abstract submissions will be reviewed by the Probiota Americas Scientific Committee - led by Dr Susan Mitmesser, Director, Nutrition Research, NBTY Inc., and made up of leading experts from the fields of pre- and probiotics. Successful abstracts will be presented as posters at the Probiota Americas conference running from June 3-5, 2015 in San Diego.

Posters will be judged on-site by the scientific committee and the winning poster authors will be invited to give a short presentation of their work to the Probiota Americas audience.

Those whose abstracts are accepted as posters will receive a 50% discount on the delegate price for Probiota. Please note that all discount information will be sent when authors are notified that their abstract has been accepted.

Here’s a video of the winners of the first Scientific Frontiers poster session at Probiota Global in Amsterdam earlier this year:

Abstracts

Abstracts are welcomed from those engaged in all aspects of microbiome science in academia, industry and consumer health, particularly those representing successful academe-industry interactions.

Early-phase, novel, or state-of-the-art research or promising ideas covering the following topics are encouraged:

Host-microbe interactions in health and disease, including preclinical and clinical studies evaluating pre- and probiotic interventions.

Application and development of “-omics” approaches in biomarker discovery, including identification of potential pre- and probiotic strains. Research identifying strain-specific effects of probiotics for health and wellbeing, including mechanism of action and bioactive discovery and isolation.

Early findings from large scale research projects and clinical trials.

Innovations and novel ideas in the areas of production processes, delivery, formulation and shelf-life

Consumer and market insights, including population research, trends and threats, commercial packaging and marketing.

Where applicable the potential for commercial application of the research should be highlighted to support the Probiota Americas aims of bridging the interface between academia and industry.

To download the abstract guidelines, please click HERE​.

Any questions about the abstract submission process or the poster session can be addressed to Dr Gemma Pearce​.

The Probiota Americas Scientific Committee:

Dr Susan Mitmesser, Director, Nutrition Research, NBTY Inc.
Prof Gregor Reid, Professor of Microbiology, Immunology and Surgery, University of Western Ontario
Dr Thomas Tompkins, Research Director, Lallemand Health Solutions
Dr Mary Ellen Sanders, Consultant, Dairy & Food Culture Technologies
Dr Deshanie Rai, Senior Associate Director, Bayer HealthCare
Dr Kimmo Makinen, Probiotic Pipeline Manager, Nestlé Research Centre
Dr David Sela, Assistant Professor, University of Massachusetts Amherst
Dr Michael Cabana, Professor of Paediatrics, Epidemiology and Biostatistics, University of California San Francisco

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 22-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Effera™ Human Equivalent Lactoferrin

Effera™ Human Equivalent Lactoferrin

Content provided by Helaina Inc | 17-May-2024 | Product Brochure

Helaina’s bioactive protein Effera™ is a novel branded ingredient and the first clinically studied Human Lactoferrin on the market. Human Lactoferrin is...

New postbiotic for gut & skin health benefits

New postbiotic for gut & skin health benefits

Content provided by Kerry ProActive Health | 14-May-2024 | Product Presentation

Plenibiotic™ (Lactobacillus casei subsp. casei 327) is a rice-derived postbiotic providing a holistic approach to digestive and skin health. It offers...

Related suppliers

Follow us

Products

View more

Webinars